Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (401-410 of 1,860) with videos related to

Pageof 186
Sort By:
The New England Journal of Medicine|August 27, 1981
beta-Adrenoceptor antagonists: new drugs and new indicationsJ Koch-Weser, W H Frishman
Bioinformatics (Oxford, England)|November 3, 2009
Pitfalls of supervised feature selectionPawel Smialowski, Dmitrij Frishman, Stefan Kramer
Archives of Internal Medicine|July 1, 1989
Calcium channel blockers in myocardial infarctionA E Skolnick, W H Frishman
Current Problems in Cardiology|February 1, 1986
Platelets and antiplatelet therapy in ischemic heart diseaseW H Frishman, K P Miller
The American Journal of Medicine|November 27, 2018
Medicine as a MeritocracyWilliam H Frishman, Joseph S Alpert
Cardiology in Review|August 12, 2010
Testosterone and coronary artery diseaseMonica D Schwarcz, William H Frishman
The American Journal of Medicine|August 24, 2013
Reducing hospital readmissions for cardiovascular disease: is it feasible?William H Frishman, Joseph S Alpert
Cardiology in Review|May 28, 2013
Brown adipose tissue thermogenesis: β3-adrenoreceptors as a potential target for the treatment of obesity in humansRoss A Mund, William H Frishman
Journal of Clinical Pharmacology|January 1, 1990
Probucol: pharmacology and clinical applicationP Zimetbaum, H Eder, W Frishman
Pharmacotherapy|January 1, 1987
Enalapril: a long-acting angiotensin-converting enzyme inhibitorM Borek, S Charlap, W Frishman
Pageof 186

Showing results (401-410 of 1,860) with videos related to

Sort By:
Pageof 186
The New England Journal of Medicine|August 27, 1981
beta-Adrenoceptor antagonists: new drugs and new indicationsJ Koch-Weser, W H Frishman
Bioinformatics (Oxford, England)|November 3, 2009
Pitfalls of supervised feature selectionPawel Smialowski, Dmitrij Frishman, Stefan Kramer
Archives of Internal Medicine|July 1, 1989
Calcium channel blockers in myocardial infarctionA E Skolnick, W H Frishman
Current Problems in Cardiology|February 1, 1986
Platelets and antiplatelet therapy in ischemic heart diseaseW H Frishman, K P Miller
The American Journal of Medicine|November 27, 2018
Medicine as a MeritocracyWilliam H Frishman, Joseph S Alpert
Cardiology in Review|August 12, 2010
Testosterone and coronary artery diseaseMonica D Schwarcz, William H Frishman
The American Journal of Medicine|August 24, 2013
Reducing hospital readmissions for cardiovascular disease: is it feasible?William H Frishman, Joseph S Alpert
Cardiology in Review|May 28, 2013
Brown adipose tissue thermogenesis: β3-adrenoreceptors as a potential target for the treatment of obesity in humansRoss A Mund, William H Frishman
Journal of Clinical Pharmacology|January 1, 1990
Probucol: pharmacology and clinical applicationP Zimetbaum, H Eder, W Frishman
Pharmacotherapy|January 1, 1987
Enalapril: a long-acting angiotensin-converting enzyme inhibitorM Borek, S Charlap, W Frishman
Pageof 186